Clinical evaluation of the 99mTc-labeled myocardial imaging agent, hexakis (t-butylisonitrile)-technetium.
99mTc-TBI myocardial perfusion imaging has been studied in 7 normal subjects and 24 patients with coronary artery disease. Scintigraphic data revealed that 99mTc-TBI myocardial perfusion imaging is more sensitive than ECG in detecting myocardial infarction. In comparing 99mTc-TBI imaging with contrast angiography, its' sensitivity for the diagnosis of coronary artery disease was 91.7%.
D000328:Adult; D000792:Angiography; D017023:Coronary Angiography; D003327:Coronary Disease / Q000175:diagnosis / Q000000981:diagnostic imaging*; D004562:Electrocardiography; D005080:Exercise Test; D005260:Female; D006321:Heart / Q000000981:diagnostic imaging*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000000981:diagnostic imaging; D009570:Nitriles; D009942:Organometallic Compounds; D015609:Organotechnetium Compounds; D011877:Radionuclide Imaging; D013667:Technetium
D009570:Nitriles; D009942:Organometallic Compounds; D015609:Organotechnetium Compounds; C043714:technetium Tc 99m hexakis(tert-butylisonitrile); D013667:Technetium